Urgent recall for asthma medication taken by thousands as health chiefs warn of wrong dose instruction
The error affecting Flutiform 250 micrograms inhalers means asthma patients could be informed of the wrong dose of the drug.
1
In its alert, UK medicines regulator, the MHRA said: "CD Pharma Ltd [the inhaler's manufacturer] have notified the MHRA of an error on the outer carton of the product for the batches listed in this notification.
"While the total active content statement is correct, the delivered dose content statement is incorrect."
The other product details on the inhaler carton, however, including the name, strength and pharmaceutical form of the medicine, are correct.
And the quality of the medicine has not been impacted by the labelling defect.
Patients have been advised to continue to take the medication as prescribed by their healthcare professionals.
Meanwhile, healthcare professionals have been advised to stop supplying the above batch immediately.
The recall urged: "Quarantine all stock and return it to your supplier using your supplier's approved process."
"This is a wholesale and pharmacy level recall that will be actioned by a healthcare professional," added the MHRA.
"There is no quality issue with the product and patients can continue to take their medicine as prescribed."
The labelling mistake means patients may have thought they were only receiving half the necessary dose of the medication.
Early Warning Signs of an Asthma Attack
As part of the recall, patients who do experience adverse reactions or have any questions about the medication are advised to seek medical attention.
Any suspected adverse reactions should also be reported via the MHRA Yellow Card Scheme.
Asthma is a common condition. In the UK, 7.2 million people have asthma. This is about eight in every 100 people, according to Asthma + Lung UK.
It affects the airways that carry air in and out of your lungs, causing them to become inflamed.
This makes the airways narrower so less air gets into and out of the lungs.
Symptoms, like wheezing, breathlessness, a cough or a tight chest, can be triggered by things like exercise, allergens or changes in weather.
At the moment there is no cure for asthma, but most people with asthma can control their symptoms well with asthma inhalers.
Depending on how severe your symptoms are, the NHS says you may be offered either:
an inhaler to use only when you get symptoms – this is called an anti-inflammatory reliever (AIR) inhaler
an inhaler to use every day to help prevent symptoms, as well as when you get symptoms – this is called a maintenance and reliever therapy (MART) inhaler
two separate inhalers – a preventer inhaler to use every day to help prevent symptoms, and a blue reliever inhaler to use when you get symptoms (you should not be given a blue reliever inhaler to use on its own)
The NHS also advises: "It's important to use your inhaler correctly so that your medicine works properly.
"There are different types, including dry powder inhalers, pMDIs and soft mist inhalers.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
14 minutes ago
- BBC News
Bedfordshire woman with ME criticises health plan for condition
A woman living with myalgic encephalomyelitis (ME) said she has "lost faith" in receiving "meaningful support" after the government released a new support plan for the also known as chronic fatigue syndrome (CFS), is a neurological disease which affects about 390,000 people in the UK. On 22 July the government launched a new delivery plan to improve education around the illness, as well as increase funding, research and medical training for health practitioners. Maddie Walker, 51, from Bedfordshire, said she was "disappointed" in how the plan lacked any "real change to improve the quality of life for sufferers". Ms Walker said she was healthy and active before she developed severe ME and was now unable to leave the house without a wheelchair and has carers visit her multiple times a described living with the condition as "mind-numbing" and that she felt "despondent". The condition's symptoms include fatigue, muscle and joint weakness, cognitive dysfunction and post-exertional malaise. Misdiagnosis Ms Walker was initially diagnosed with fibromyalgia with fatigue, a condition causing muscular pain all over the body. As a result of the crossover in symptoms, Ms Walker's ME was not recognised initially, leading her to be recommended treatment that was not tailored to both conditions."Something I feel really strongly about is people being given the right information at the point of diagnosis because if I had known what I was doing was harmful, I might not be in this situation."Ms Walker said she has a "terrible, really poor quality of life" and that "hundreds of thousands of people have once again been let down" by the new delivery plan. "We just aren't important enough," she said. The ME Association (MEA) said the government must go "much further" to improve medical care and funding for "much needed" biomedical research. It added that currently most research studies for ME/CFS are funded by the charity added there were numerous strengths to the plan, including the approach to broaden education about the illness in the NHS and in schools. Dr Charles Shepherd, a medical adviser with the MEA, said the plan does not align with the 2021 National Institute for Health and Care Excellence guidelines, which suggested making referral services more accessible in hospitals. Ashley Dalton, the MP for West Lancashire and minister for public health and prevention, said: "[The] plan will help tackle the stigma and lack of awareness of this condition through improved training for NHS staff." A spokesperson of Department for Health and Social Care (DHSC) said: "We acknowledge there is more to be done and will continue to build on the foundations of these actions well beyond the publication of this plan."There was a "clear commitment" to achieving "meaningful change" for the ME/CFS community, it using neighbourhood health services, the DHSC said it will ensure patients can access quality care closer to home. Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X.
The Independent
an hour ago
- The Independent
Trump's hand makeup is back during Scotland trip as he deals with chronic venous insufficiency
President Donald Trump 's hand makeup is back as he meets with world leaders between games of golf on his trip to Scotland. Photographs of the president's meeting with European Commission President Ursula von der Leyen on Sunday showed the back of his right hand apparently caked in concealer. It was also evident on Monday, ahead of his meeting with U.K. Prime Minister Sir Keir Starmer, and on Friday as he departed the White House on Marine One. Trump, 79, has persistent bruising on his hand that has previously been attributed to the large number of handshakes he gives and receives in his role as president and an aspirin regimen, though that has done little to quell speculation on social media. The bruising was acknowledged in a July 17 medical report that also diagnosed Trump with chronic venous insufficiency (CVI), a benign and common condition, prevalent in people over the age of 70. The apparent need to cover the bruising with makeup has not been explained. As the oldest president ever to be elected and take office, Trump's health and mental acuity have been a concern since his inauguration in January, though the White House is adamant he 'remains in excellent health.' In February, during a visit to the White House by President Emmanuel Macron of France, a large bruise was noticed on the back of Trump's right hand, sparking speculation about its cause. More recently, the use of makeup was noticed in photos, and questions were also raised about what appeared to be swelling around his ankles during his attendance at the FIFA Club World Cup Final. Shortly after, Press Secretary Karoline Leavitt released a letter from the White House physician confirming that a doctor had seen the president for a 'comprehensive examination,' the conclusion of which was the diagnosis of CVI — a condition in which veins struggle to manage blood flow, making it hard for blood to return to the heart. The report by Sean Barbabella, the president's physician, also noted: 'Recent photos of the president have shown minor bruising on the back of his hand. This is consistent with minor soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen.'
BreakingNews.ie
an hour ago
- BreakingNews.ie
Physiotherapist who gave Botox-like drug to clients suspended for three months
A physiotherapist who administered an unlicensed Botox-like product to a number of clients and was found guilty of poor professional performance has been suspended for three months by the High Court. High Court president Mr Justice David Barniville confirmed the sanction of CORU the regulatory body of health and social care professionals to suspend the Dublin physiotherapist from the Register of Physiotherapists for three months starting in October. Advertisement Physiotherapist, Igor Castro, who operates a practice on O'Connell St in Dublin, appeared before a fitness-to-practise inquiry earlier this year over his use and promotion of Liztox, a Korean botulinum toxin product similar to Botox which is used for aesthetic treatments. The CORU fitness-to-practise committee found an allegation proven that Mr Castro had administered Liztox to three clients at his practice in October 2023. The committee also found it proven that the Brazilian native had posted one or more posts on his Instagram account between October and November 2023 promoting the fact that he was administering the Botox-like product to clients. In the High Court on Monday, CORU solicitor JP McDowell of Fieldfisher solicitors said the committee regarded it as a very serious matter 'and it goes to the issue of public safety.' Advertisement He said mitigating factors were considered including that Mr Castro had ' considerable insight into the error of his ways.' Confirming the suspension to begin in October, Mr Justice David Barniville noted that Mr Castro had made a full admission and was very apologetic for what happened . At the CORU fitness to practise committee inquiry last January the inquiry's chairwoman, Geraldine Feeney, said the committee made its findings on the basis of Mr Castro's own admissions and the uncontroverted evidence of a number of witnesses including an enforcement officer with the Health Products Regulatory Authority. She said Mr Castro's actions in administering Liztox when it was outside his scope as a physiotherapist also represented breaches of the profession's code of professional conduct and ethics. Ms Feeney added: Advertisement The committee observed that an expert witness had pointed out that Mr Castro was not legally qualified to administer an unlicensed product which was a 'potentially harmful substance'. Ireland Elon Musk's X to commence Labour Court appeal agai... Read More Ms Feeney said the physiotherapist had demonstrated extremely poor judgement and brought the profession into disrepute. She acknowledged that Mr Castro had co-operated fully from the outset with an investigation by the HPRA and subsequently the CORU inquiry and had made complete admissions about his conduct which she said had demonstrated insight into his wrongdoing. She noted that the committee was satisfied that there was little or no risk that Mr Castro would repeat the conduct in future based on his evidence, insight, and statement of regret. She acknowledged that he had provided the inquiry with several references which described him as a 'conscientious and good' physiotherapist. Ms Feeney said the committee was also impressed by the fact that Mr Castro was undertaking continuous education for the purpose of improving his skills and providing physiotherapy services.
